Alerts will be sent to your verified email
Verify EmailPATIDAR
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Established in 1986, Patidar Buildcon Ltd diversifies into pharmaceutical sector manufacturing anti-fungal, anti-TB, anti-asthmatics, serums, and vaccines.
Patidar Buildcon major competitors are Athena Constructions, Epsom Properties, Mega Nirman & Inds., Regaliaa Realty, Unishire Urban, Relstruct Buildcon, Asahi Infra &Project.
Market Cap of Patidar Buildcon is ₹6 Crs.
While the median market cap of its peers are ₹6 Crs.
Patidar Buildcon seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.